Targeting the microglial signaling pathways: New insights in the modulation of neuropathic pain

Current Medicinal Chemistry

Volumn 23, Issue 26, 2016, Pages 2908-2928

  Popiolek Barczyk, Katarzyna ^a   Mika, Joanna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

ERK1 2; MAPK; Microglia; Neuropathic pain; NF B; P38; PI3K Akt; STAT

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT PROTEIN;

ANTINOCICEPTION; ASTROCYTE; CELL FUNCTION; CELL INTERACTION; CELL POLARITY; ENZYME INHIBITION; HUMAN; INTRACELLULAR SIGNALING; KINASE ASSAY; MICROGLIA; NERVE CELL; NEUROPATHIC PAIN; REVIEW; CENTRAL NERVOUS SYSTEM; METABOLISM; NEURALGIA; PATHOLOGY; SIGNAL TRANSDUCTION;

CENTRAL NERVOUS SYSTEM; HUMANS; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NEURALGIA; NEURONS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84989159490     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666160607120124     Document Type: Review

References (210)

1. Merskey, H.; Bogduk, N. Classification of Chronic Pain; IASP Press: Seattle, 1994.
2. Coyle, D. E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia, 1998, 23, 75-83.
3. Dworkin, R. H.; O-Connor, A. B.; Audette, J.; Baron, R.; Gourlay, G. K.; Haanpaa, M. L.; Kent, J. L.; Krane, E. J.; Lebel, A. A.; Levy, R. M.; Mackey, S. C.; Mayer, J.; Miaskowski, C.; Raja, S. N.; Rice, A. S. C.; Schmader, K. E.; Stacey, B.; Stanos, S.; Treede, R. D.; Turk, D. C.; Walco, G. A.; Wells, C. D. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin. Proc., 2010, 85, S3-S14.
4. Kalso, E.; Allan, L.; Dellemijn, P. L. I.; Faura, C. C.; Ilias, W. K.; Jensen, T. S.; Perrot, S.; Plaghki, L. H.; Zenz, M. Recommendations for using opioids in chronic non-cancer pain. Eur. J. Pain, 2003, 7, 381-386.
5. Kalso, E.; Edwards, J. E.; Moore, R. A.; McQuay, H. J. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain, 2004, 112, 372-380.
6. Amir, R.; Kocsis, J. D.; Devor, M. Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons. J. Neurosci., 2005, 25, 2576-2585.
7. Devor, M. Sodium channels and mechanisms of neuropathic pain. J. Pain, 2006, 7, S3-S12.
8. Wu, G.; Ringkamp, M.; Hartke, T. V; Murinson, B. B.; Campbell, J. N.; Griffin, J. W.; Meyer, R. A. Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J. Neurosci., 2001, 21, 21.
9. Colombo, E.; Francisconi, S.; Faravelli, L.; Izzo, E.; Pevarello, P. Ion channel blockers for the treatment of neuropathic pain. Future Med. Chem., 2010, 2, 803-842.
10. Khan, N.; Smith, M. Neurotrophins and neuropathic pain: role in pathobiology. Molecules, 2015, 20, 10657-10688.
11. Obara, I.; Goulding, S. P.; Hu, J. H.; Klugmann, M.; Worley, P. F.; Szumlinski, K. K. Nerve injury-induced changes in Homer/glutamate receptor signaling contribute to the development and maintenance of neuropathic pain. Pain, 2013, 154, 1932-1945.
12. Woolf, C. J.; Ma, Q. Nociceptors-Noxious Stimulus Detectors. Neuron, 2007, 55, 353-364.
13. Ji, R. R.; Strichartz, G. Cell signaling and the genesis of neuropathic pain. Sci. STKE, 2004, 2004, reE14.
14. Mika, J.; Rojewska, E.; Makuch, W.; Przewlocka, B. Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain. Neuroscience, 2010, 165, 1420-1428.
15. Mika, J.; Popiolek-Barczyk, K.; Rojewska, E.; Makuch, W.; Starowicz, K.; Przewlocka, B. Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain. PLoS One, 2014, 9, e104420.
16. Rojewska, E.; Popiolek-Barczyk, K.; Jurga, A. M.; Makuch, W.; Przewlocka, B.; Mika, J. Involvement of pro-and antinociceptive factors in minocycline analgesia in rat neuropathic pain model. J. Neuroimmunol., 2014, 277, 57-66.
17. Ji, R. R.; Kohno, T.; Moore, K. A.; Woolf, C. J. Central sensitization and LTP: Do pain and memory share similar mechanisms? Trends Neurosci., 2003, 26, 696-705.
18. Mantyh, P. W.; Clohisy, D. R.; Koltzenburg, M.; Hunt, S. P. Molecular mechanisms of cancer pain. Nat. Rev. Cancer, 2002, 2, 201-209.
19. Woolf, C. J.; Salter, M. W. Neuronal plasticity: increasing the gain in pain. Science, 2000, 288, 1765-1769.
20. Zhuo, M.; Wu, G.; Wu, L. J. Neuronal and microglial mechanisms of neuropathic pain. Mol. Brain, 2011, 4, 31.
21. Zhuo, M. Neuronal mechanism for neuropathic pain. Mol. Pain, 2007, 3, 14.
22. Popiolek-Barczyk, K.; Rojewska, E.; Jurga, A. M.; Makuch, W.; Zador, F.; Borsodi, A.; Piotrowska, A.; Przewlocka, B.; Mika, J. Minocycline enhances the effectiveness of nociceptin/ orphanin FQ during neuropathic pain. Biomed. Res. Int., 2014, 2014, 1-12.
23. Popiolek-Barczyk, K.; Makuch, W.; Rojewska, E.; Pilat, D.; Mika, J. Inhibition of intracellular signaling pathways NF-?B and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia. Pharmacol. Rep., 2014, 66, 845-851.
24. Popiolek-Barczyk, K.; Kolosowska, N.; Piotrowska, A.; Makuch, W.; Rojewska, E.; Jurga, A. M.; Pilat, D.; Mika, J. Parthenolide relieves pain and promotes M2 microglia/ macrophage polarization in rat model of neuropathy. Neural Plast., 2015, 2015, 1-15.
25. Osikowicz, M.; Skup, M.; Mika, J.; Makuch, W.; Czarkowska-Bauch, J.; Przewlcka, B. Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain. Pain, 2009, 147, 175-186.
26. Makuch, W.; Mika, J.; Rojewska, E.; Zychowska, M.; Przewlocka, B. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine-and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Neuropharmacology, 2013, 75, 445-457.
27. Miyoshi, K.; Obata, K.; Kondo, T.; Okamura, H.; Noguchi, K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J. Neurosci., 2008, 28, 12775-12787.
28. Dominguez, E.; Rivat, C.; Pommier, B.; Mauborgne, A.; Pohl, M. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J. Neurochem., 2008, 107, 50-60.
29. Mika, J.; Zychowska, M.; Popiolek-Barczyk, K.; Rojewska, E.; Przewlocka, B. Importance of glial activation in neuropathic pain. Eur. J. Pharmacol., 2013, 716, 106-119.
30. Zychowska, M.; Rojewska, E.; Przewlocka, B.; Mika, J. Mechanisms and pharmacology of diabetic neuropathy-experimental and clinical studies. Pharmacol. Rep., 2013, 65, 1601-1610.
31. Austin, P. J.; Moalem-Taylor, G. The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol., 2010, 229, 26-50.
32. Austin, P. J.; Berglund, A. M.; Siu, S.; Fiore, N. T.; Gerke-Duncan, M. B.; Ollerenshaw, S. L.; Leigh, S. J.; Kunjan, P. A.; Kang, J. W.; Keay, K. A. Evidence for a distinct neuroimmune signature in rats that develop behavioural disability after nerve injury. J. Neuroinflammation, 2015, 12, 96.
33. Buchanan, M. M.; Hutchinson, M.; Watkins, L. R.; Yin, H. Toll-like receptor 4 in CNS pathologies. J. Neurochem., 2010, 114, 13-27.
34. Grace, P. M.; Hutchinson, M. R.; Maier, S. F.; Watkins, L. R. Pathological pain and the neuroimmune interface. Nat. Rev. Immunol., 2014, 14, 217-231.
35. Machelska, H. Dual peripheral actions of immune cells in neuropathic pain. Arch. Immunol. Ther. Exp. (Warsz)., 2011, 59, 11-24.
36. Mika, J.; Osikowicz, M.; Makuch, W.; Przewlocka, B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur. J. Pharmacol., 2007, 560, 142-149.
37. Mika, J.; Wawrzczak-Bargiela, A.; Osikowicz, M.; Makuch, W.; Przewlocka, B. Attenuation of morphinetolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain. Behav. Immun., 2009, 23, 75-84.
38. Rojewska, E.; Korostynski, M.; Przewlocki, R.; Przewlocka, B.; Mika, J. Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain. Mol. Pain, 2014, 10, 47.
39. Nedergaard, M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science, 1994, 263, 1768-1771.
40. Roh, D. H.; Yoon, S. Y.; Seo, H. S.; Kang, S. Y.; Han, H. J.; Beitz, A. J.; Lee, J. H. Intrathecal injection of carbenoxolone, a gap junction decoupler, attenuates the induction of belowlevel neuropathic pain after spinal cord injury in rats. Exp. Neurol., 2010, 224, 123-132.
41. Zundorf, G.; Kahlert, S.; Reiser, G. Gap-junction blocker carbenoxolone differentially enhances NMDA-induced cell death in hippocampal neurons and astrocytes in co-culture. J. Neurochem., 2007, 102, 508-521.
42. Haber, M.; Murai, K. K. Reshaping neuron-glial communication at hippocampal synapses. Neuron Glia Biol., 2006, 2, 59-66.
43. Haber, M.; Zhou, L.; Murai, K. K. Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses. J. Neurosci., 2006, 26, 8881-8891.
44. Jourdain, P.; Bergersen, L. H.; Bhaukaurally, K.; Bezzi, P.; Santello, M.; Domercq, M.; Matute, C.; Tonello, F.; Gundersen, V.; Volterra, A. Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci., 2007, 10, 331-339.
45. Oliet, S. H. R.; Panatier, A.; Piet, R.; Mothet, J. P.; Poulain, D. A.; Theodosis, D. T. Neuron-glia interactions in the rat supraoptic nucleus. Prog. Brain Res., 2008, 170, 109-117.
46. Hatori, K.; Nagai, A.; Heisel, R.; Ryu, J. K.; Kim, S. U. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res., 2002, 69, 418-426.
47. Ren, K.; Dubner, R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr. Opin. Anaesthesiol., 2008, 21, 570-579.
48. Rocha, S. M.; Pires, J.; Esteves, M.; Graca, B.; Bernardino, L. Histamine: A new immunomodulatory player in the neuron-glia crosstalk. Front. Cell. Neurosci., 2014, 8, 120.
49. Eriksson, N. P.; Persson, J. K. E.; Aldskogius, H.; Svensson, M. A quantitative analysis of the glial cell reaction in primary sensory termination areas following sciatic nerve injury and treatment with nerve growth factor in the adult rat. Exp. Brain Res., 1997, 114, 393-404.
50. Garrison, C. J.; Dougherty, P. M.; Kajander, K. C.; Carlton, S. M. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res., 1991, 565, 1-7.
51. Dreger, M.; Mika, J.; Bieller, A.; Jahnel, R.; Gillen, C.; Schaefer, M. K.; Weihe, E.; Hucho, F. Analysis of the dorsal spinal cord synaptic architecture by combined proteome analysis and in situ hybridization. J. Proteome Res., 2005, 4, 238-249.
52. Mika, J.; Osikowicz, M.; Rojewska, E.; Korostynski, M.; Wawrzczak-Bargiela, A.; Przewlocki, R.; Przewlocka, B. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur. J. Pharmacol., 2009, 623, 65-72.
53. Rodriguez Parkitna, J.; Korostynski, M.; Kaminska-Chowaniec, D.; Obara, I.; Mika, J.; Przewlocka, B.; Przewlocki, R. Comparison of gene expression profiles in neuropathic and inflammatory pain. J. Physiol. Pharmacol., 2006, 57, 401-414.
54. Gong, Q. J.; Li, Y. Y.; Xin, W. J.; Zhang, Y.; Ren, W. J.; Wei, X. H.; Li, Y. Y.; Zhang, T.; Liu, X. G. ATP induces longterm potentiation of C-fiber-evoked field potentials in spinal dorsal horn: The roles of P2X4 receptors and p38 MAPK in microglia. Glia, 2009, 57, 583-591.
55. Chu, Y. X.; Zhang, Y.; Zhang, Y. Q.; Zhao, Z. Q. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses. Brain. Behav. Immun., 2010, 24, 1176-1189.
56. Gwak, Y. S.; Kang, J.; Unabia, G. C.; Hulsebosch, C. E. Spatial and temporal activation of spinal glial cells: Role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp. Neurol., 2012, 234, 362-372.
57. Tanga, F.; Raghavendra, V.; DeLeo, J. A. Quantitative realtime RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int., 2004, 45, 397-407.
58. Clark, A. K.; Yip, P. K.; Grist, J.; Gentry, C.; Staniland, A. A; Marchand, F.; Dehvari, M.; Wotherspoon, G.; Winter, J.; Ullah, J.; Bevan, S.; Malcangio, M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 10655-10660.
59. Clark, A. K.; Gentry, C.; Bradbury, E. J.; McMahon, S. B.; Malcangio, M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain, 2007, 11, 223-230.
60. Zhang, J.; De Koninck, Y. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J. Neurochem., 2006, 97, 772-783.
61. Zhuang, Z. Y.; Wen, Y. R.; Zhang, D. R.; Borsello, T.; Bonny, C.; Strichartz, G. R.; Decosterd, I.; Ji, R. R. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci., 2006, 26, 3551-3560.
62. Gritsch, S.; Lu, J.; Thilemann, S.; Wortge, S.; Mobius, W.; Bruttger, J.; Karram, K.; Ruhwedel, T.; Blanfeld, M.; Vardeh, D.; Waisman, A.; Nave, K. A.; Kuner, R. Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice. Nat. Commun., 2014, 5, 5472.
63. Zarpelon, A. C.; Rodrigues, F. C.; Lopes, A. H.; Souza, G. R.; Carvalho, T. T.; Pinto, L. G.; Xu, D.; Ferreira, S. H.; Alves-Filho, J. C.; McInnes, I. B.; Ryffel, B.; Quesniaux, V. F. J.; Reverchon, F.; Mortaud, S.; Menuet, A.; Liew, F. Y.; Cunha, F. Q.; Cunha, T. M.; Verri, W. A. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB J., 2016, 30, 54-65.
64. Liu, S.; Mi, W. L.; Li, Q.; Zhang, M. T.; Han, P.; Hu, S.; Mao-Ying, Q. L. W. Y. Spinal IL-33/ST2 signaling contributes to neuropathic pain via neuronal CaMKIICREB and astroglial JAK2-STAT3 cascades in mice. Anesthesiology, 2015.
65. Colburn, R. W.; Rickman, A. J.; DeLeo, J. A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol., 1999, 157, 289-304.
66. Romero-Sandoval, E. A.; Horvath, R. J.; DeLeo, J. A. Neuroimmune interactions and pain: focus on glialmodulating targets. Curr. Opin. Investig. Drugs, 2008, 9, 726-734.
67. Liu, B.; Neufeld, A. H. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia, 2000, 30, 178-186.
68. Dirig, D. M.; Yaksh, T. L. Spinal synthesis and release of prostanoids after peripheral injury and inflammation. Adv Exp. Med. Biol., 1999, 401-408.
69. Ghilardi, J. R. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J. Neurosci., 2004, 24, 2727-2732.
70. Duan, S.; Anderson, C. M.; Keung, E. C.; Chen, Y.; Chen, Y.; Swanson, R. A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci., 2003, 23, 1320-1328.
71. Gao, Y. J.; Zhang, L.; Samad, O. A.; Suter, M. R.; Yasuhiko, K.; Xu, Z. Z.; Park, J. Y.; Lind, A. L.; Ma, Q.; Ji, R. R. JNKinduced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J. Neurosci., 2009, 29, 4096-4108.
72. Kawasaki, Y.; Xu, Z. Z.; Wang, X.; Park, J. Y.; Zhuang, Z. Y.; Tan, P. H.; Gao, Y. J.; Roy, K.; Corfas, G.; Lo, E. H.; Ji, R. R. Distinct roles of matrix metalloproteases in the early-and late-phase development of neuropathic pain. Nat. Med., 2008, 14, 331-336.
73. Queiroz, G.; Gebicke-Haerter, P.; Schobert, A.; Starke, K.; von Kugelgen, I. Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience, 1997, 78, 1203-1208.
74. Griffin, R. S.; Costigan, M.; Brenner, G. J.; Him Eddie Ma, C.; Scholz, J.; Moss, A.; Allchorne, A. J.; Stahl, G. L.; Woolf, C. J. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J. Neurosci., 2007, 27, 8699-8708.
75. Graeber, M. B. Changing face of microglia. Science, 2010, 330, 783-788.
76. McMahon, S. B.; Cafferty, W. B. J.; Marchand, F. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol., 2005, 192, 444-462.
77. Slusarczyk, J.; Trojan, E.; Glombik, K.; Budziszewska, B.; Kubera, M.; Lason, W.; Popiolek-Barczyk, K.; Mika, J.; Wedzony, K.; Basta-Kaim, A. Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells. Front. Cell. Neurosci., 2015, 9, 1-14.
78. Slusarczyk, J.; Trojan, E.; Glombik, K.; Piotrowska, A.; Budziszewska, B.; Kubera, M.; Popiolek-Barczyk, K.; Lason, W.; Mika, J.; Basta-Kaim, A. Anti-inflammatory properties of tianeptine on lipopolysaccharide-induced changes in microglial cells involve Toll-like receptorrelated pathways. J. Neurochem., 2016, 136(5), 958-970.
79. Bedard, A.; Tremblay, P.; Chernomoretz, A.; Vallieres, L. Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation. Glia, 2007, 55, 777-789.
80. Lehnardt, S.; Massillon, L.; Follett, P.; Jensen, F. E.; Ratan, R.; Rosenberg, P. A.; Volpe, J. J.; Vartanian, T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 8514-8519.
81. Kettenmann, H.; Kirchhoff, F.; Verkhratsky, A. Microglia: new roles for the synaptic stripper. Neuron, 2013, 77, 10-18.
82. Jurga, A. M.; Piotrowska, A.; Starnowska, J.; Rojewska, E.; Makuch, W.; Mika, J. Treatment with a carbon monoxidereleasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats. Pharmacol. Reports, 2016, 68, 206-213.
83. Verkhratsky, A.; Kettenmann, H. Calcium signalling in glial cells. Trends Neurosci., 1996, 19, 346-352.
84. Inoue, K. The functions of ATP receptors in the hippocampus. Pharmacol. Res., 1998, 38, 323-331.
85. Hide, I.; Tanaka, M.; Inoue, A.; Nakajima, K.; Kohsaka, S.; Inoue, K.; Nakata, Y. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem., 2000, 75, 965-972.
86. Shigemoto-Mogami, Y.; Koizumi, S.; Tsuda, M.; Ohsawa, K.; Kohsaka, S.; Inoue, K. Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J. Neurochem., 2001, 78, 1339-1349.
87. Tsuda, M.; Shigemoto-Mogami, Y.; Koizumi, S.; Mizokoshi, A.; Kohsaka, S.; Salter, M. W.; Inoue, K. P2X(4) receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 2003, 424, 778-783.
88. Pannell, M.; Meier, M. A.; Szulzewsky, F.; Matyash, V.; Endres, M.; Kronenberg, G.; Prinz, V.; Waiczies, S.; Wolf, S. A.; Kettenmann, H. The subpopulation of microglia expressing functional muscarinic acetylcholine receptors expands in stroke and Alzheimer-s disease. Brain Struct. Funct., 2014, 19, 19.
89. Lee, Y. B.; Nagai, A.; Kim, S. U. Cytokines, chemokines, and cytokine receptors in human microglia. J. Neurosci. Res., 2002, 69, 94-103.
90. Malek, N.; Popiolek-Barczyk, K.; Mika, J.; Przewlocka, B.; Starowicz, K. Anandamide, acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures. Neural Plast., 2015, 2015, 1-10.
91. Dong, H.; Zhang, W.; Zeng, X.; Hu, G.; Zhang, H.; He, S.; Zhang, S. Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol. Neurobiol., 2014, 49, 1487-1500.
92. Elkabes, S.; Peng, L.; Black, I. B. Lipopolysaccharide differentially regulates microglial Trk receptor and neurotrophin expression. J. Neurosci. Res., 1998, 54, 117-122.
93. Harrison, J. K.; Jiang, Y.; Chen, S.; Xia, Y.; Maciejewski, D.; McNamara, R. K.; Streit, W. J.; Salafranca, M. N.; Adhikari, S.; Thompson, D. A; Botti, P.; Bacon, K. B.; Feng, L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 10896-10901.
94. Wolf, Y.; Yona, S.; Kim, K. W.; Jung, S. Microglia, seen from the CX3CR1 angle. Front. Cell. Neurosci., 2013, 7, 26.
95. Clark, A. K.; Malcangio, M. Fractalkine/CX3CR1 signaling during neuropathic pain. Front. Cell. Neurosci., 2014, 8, 121.
96. Boddeke, E. W. Involvement of chemokines in pain. Eur. J. Pharmacol., 2001, 429, 115-119.
97. Johnston, I.; Milligan, E.; Wieseler-Frank, J. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci., 2004, 24, 7353-7365.
98. Opree, A.; Kress, M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J. Neurosci., 2000, 20, 6289-6293.
99. Pilat, D.; Rojewska, E.; Jurga, A. M.; Piotrowska, A.; Makuch, W.; Przewlocka, B.; Mika, J. IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model. Eur. J. Pharmacol., 2015, 764, 240-248.
100. Yezierski, R. P.; DeLeo, J. A. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain, 2001, 90, 1-6.
101. Kwiatkowski, K.; Piotrowska, A.; Rojewska, E.; Makuch, W.; Jurga, A.; Slusarczyk, J.; Trojan, E.; Basta-Kaim, A.; Mika, J. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats. Prog. Neuro-Psychopharmacology Biol. Psychiatry, 2016, 64, 68-78.
102. Ginhoux, F.; Greter, M.; Leboeuf, M.; Nandi, S.; See, P.; Gokhan, S.; Mehler, M. F.; Conway, S. J.; Ng, L. G.; Stanley, E. R.; Samokhvalov, I. M.; Merad, M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science, 2010, 330, 841-845.
103. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol., 2004, 25, 677-686.
104. Martinez, F. O.; Gordon, S. The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep., 2014, 6, 1-13.
105. Steinman, R.; Idoyaga, J. Features of the dendritic cell lineage. Immunol. Rev., 2010, 234, 5-17.
106. Pan, J.; Jin, J.; Ge, H.; Yin, K.; Chen, X.; Han, L.; Chen, Y.; Qian, L.; Li, X.; Xu, Y. Malibatol A regulates microglia M1/M2 polarization in experimental stroke in a PPAR?-dependent manner. J. Neuroinflammation, 2015, 12, 51.
107. Pisanu, A.; Lecca, D.; Mulas, G.; Wardas, J.; Simbula, G.; Spiga, S.; Carta, A. R. Dynamic changes in pro-and antiinflammatory cytokines in microglia after PPAR-? agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson-s disease. Neurobiol. Dis., 2014, 71, 280-291.
108. Burke, N. N.; Kerr, D. M.; Moriarty, O.; Finn, D. P.; Roche, M. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain. Behav. Immun., 2014, 147-156.
109. Kobayashi, K.; Imagama, S.; Ohgomori, T.; Hirano, K.; Uchimura, K.; Sakamoto, K.; Hirakawa, A.; Takeuchi, H.; Suzumura, A.; Ishiguro, N.; Kadomatsu, K. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis., 2013, 4, e525.
110. Labuzek, K.; Liber, S.; Gabryel, B.; Okopie?, B. Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacol. Reports, 2010, 62, 827-848.
111. Orihuela, R.; McPherson, C. A.; Harry, G. J. Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol., 2016, 173(4), 649-665.
112. Przanowski, P.; Dabrowski, M.; Ellert-Miklaszewska, A.; Kloss, M.; Mieczkowski, J.; Kaza, B.; Ronowicz, A.; Hu, F.; Piotrowski, A.; Kettenmann, H.; Komorowski, J.; Kaminska, B. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. J. Mol. Med., 2014, 92, 239-254.
113. Koscso, B.; Csoka, B.; Kokai, E.; Nemeth, Z. H.; Pacher, P.; Virag, L.; Leibovich, S. J.; Hasko, G. Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages. J. Leukoc. Biol., 2013, 94, 1309-1315.
114. Zhou, X.; Spittau, B.; Krieglstein, K. TGF? signalling plays an important role in IL4-induced alternative activation of microglia. J. Neuroinflammation, 2012, 9, 210.
115. Xu, F.; Huang, J.; He, Z.; Chen, J.; Tang, X.; Song, Z.; Guo, Q.; Huang, C. Microglial polarization dynamics in dorsal spinal cord in the early stages following chronic sciatic nerve damage. Neurosci. Lett., 2016, 617, 6-13.
116. Ji, R. R.; Baba, H.; Brenner, G. J.; Woolf, C. J. Nociceptivespecific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat. Neurosci., 1999, 2, 1114-1119.
117. Ji, R. R.; Samad, T. A.; Jin, S. X.; Schmoll, R.; Woolf, C. J. P38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron, 2002, 36, 57-68.
118. Karim, F.; Wang, C. C.; Gereau, R. W. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J. Neurosci., 2001, 21, 3771-3779.
119. Pezet, S.; Malcangio, M.; Lever, I. J.; Perkinton, M. S.; Thompson, S. W. N.; Williams, R. J.; McMahon, S. B. Noxious stimulation induces Trk receptor and downstream ERK phosphorylation in spinal dorsal horn. Mol. Cell. Neurosci., 2002, 21, 684-695.
120. Hains, B. C.; Waxman, S. G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci., 2006, 26, 4308-4317.
121. Ji, R. R.; Suter, M. R. P38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain, 2007, 3, 33.
122. Piotrowska, A.; Kwiatkowski, K.; Rojewska, E.; Makuch, W.; Mika, J. Maraviroc reduces neuropathic pain through polarization of microglia and astroglia-evidence from in vivo and in vitro studies. Neuropharmacology, 2016, 207-219.
123. Zhuang, Z. Y.; Gerner, P.; Woolf, C. J.; Ji, R. R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain, 2005, 114, 149-159.
124. Tsuda, M.; Mizokoshi, A.; Shigemoto-Mogami, Y.; Koizumi, S.; Inoue, K. Activation of p38 Mitogen-Activated Protein Kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia, 2004, 45, 89-95.
125. Ma, W.; Quirion, R. Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signalregulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain, 2002, 99, 175-184.
126. Ma, W.; Quirion, R. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin. Ther. Targets, 2005, 9, 699-713.
127. Xu, Z.; Wang, B. R.; Wang, X.; Kuang, F.; Duan, X. L.; Jiao, X. Y.; Ju, G. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. Life Sci., 2006, 79, 1895-1905.
128. Jin, S. X.; Zhuang, Z. Y.; Woolf, C. J.; Ji, R. R. P38 Mitogen-Activated Protein Kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci., 2003, 23, 4017-4022.
129. Rojewska, E.; Popiolek-Barczyk, K.; Kolosowska, N.; Piotrowska, A.; Zychowska, M.; Makuch, W.; Przewlocka, B.; Mika, J. PD98059 influences immune factors and enhances opioid analgesia in model of neuropathy. PLoS One., 2015, 10, e0138583.
130. Wen, Y.; Suter, M.; Kawasaki, Y.; Huang, J.; Pertin, M.; Kohno, T.; Berde, C.; Decosterd, I.; Ji, R. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology, 2007, 107, 312-321.
131. Zhou, X.; Cheng, H.; Xu, D.; Yin, Q.; Cheng, L.; Wang, L.; Song, S.; Zhang, M. Attenuation of neuropathic pain by saikosaponin a in a rat model of chronic constriction injury. Neurochem. Res., 2014, 2136-2142.
132. Zhou, T. T.; Wu, J. R.; Chen, Z. Y.; Liu, Z. X.; Miao, B. Effects of dexmedetomidine on P2X4Rs, p38-MAPK and BDNF in spinal microglia in rats with spared nerve injury. Brain Res., 2014, 1568, 21-30.
133. Rojewska, E.; Popiolek-Barczyk, K.; Jurga, A. M.; Makuch, W.; Przewlocka, B.; Mika, J. Involvement of pro-and antinociceptive factors in minocycline analgesia in rat neuropathic pain model. J. Neuroimmunol., 2014, 277, 57-66.
134. Obata, K.; Yamanaka, H.; Dai, Y.; Mizushima, T.; Fukuoka, T.; Tokunaga, A.; Noguchi, K. Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats. Eur. J. Neurosci., 2004, 20, 2881-2895.
135. Taves, S.; Berta, T.; Liu, D. L.; Gan, S.; Chen, G.; Kim, Y. H.; Van de Ven, T.; Laufer, S.; Ji, R. R. Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord. Brain. Behav. Immun., 2016, 55, 70-81.
136. Wen, Y.; Suter, M.; Kawasaki, Y.; Huang, J.; Pertin, M.; Kohno, T.; Berde, C.; Decosterd, I.; Ji, R. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology., 2007, 107, 312-321.
137. Milligan, E. D.; Twining, C.; Chacur, M.; Biedenkapp, J.; O-Connor, K.; Poole, S.; Tracey, K.; Martin, D.; Maier, S. F.; Watkins, L. R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci., 2003, 23, 1026-1040.
138. Mei, X. P.; Sakuma, Y.; Xie, C.; Wu, D.; Ho, I.; Kotani, J.; Xu, L. X. Depressing interleukin-1? contributed to the synergistic effects of tramadol and minocycline on spinal nerve ligation-induced neuropathic pain. Neurosignals., 2013, 710032, 1-13.
139. Raghavendra, V.; Tanga, F.; DeLeo, J. A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther., 2003, 306, 624-630.
140. Ledeboer, A.; Sloane, E. M.; Milligan, E. D.; Frank, M. G.; Mahony, J. H.; Maier, S. F.; Watkins, L. R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain, 2005, 115, 71-83.
141. Sorge, R. E.; Mapplebeck, J. C. S.; Rosen, S.; Beggs, S.; Taves, S.; Alexander, J. K.; Martin, L. J.; Austin, J. S.; Sotocinal, S. G.; Chen, D.; Yang, M.; Shi, X. Q.; Huang, H.; Pillon, N. J.; Bilan, P. J.; Tu, Y.; Klip, A.; Ji, R.-R.; Zhang, J.; Salter, M. W.; Mogil, J. S. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat. Neurosci., 2015, 18, 1-5.
142. Berta, T.; Park, C. K.; Xu, Z. Z.; Xie, R. G.; Liu, T.; Lu, N.; Liu, Y. C.; Ji, R. R. Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-? secretion. J. Clin. Invest., 2014, 124, 1173-1186.
143. Kaminska, B.; Gozdz, A.; Zawadzka, M.; Ellert-Miklaszewska, A.; Lipko, M. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat. Rec., 2009, 292, 1902-1913.
144. Lin, X.; Wang, M.; Zhang, J.; Xu, R. P38 MAPK: A potential target of chronic pain. Curr. Med. Chem., 2014, 21, 4405-4418.
145. Sung, C. S.; Wen, Z. H.; Chang, W. K.; Chan, K. H.; Ho, S. T.; Tsai, S. K.; Chang, Y. C.; Wong, C. S. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J. Neurochem., 2005, 94, 742-752.
146. Svensson, C. I.; Hua, X. Y.; Protter, A. A.; Powell, H. C.; Yaksh, T. L. Spinal p38 MAP kinase is necessary for NMDA-induced spinal PGE(2) release and thermal hyperalgesia. Neuroreport, 2003, 14, 1153-1157.
147. Kumar, S.; Boehm, J.; Lee, J. C. P38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov., 2003, 2, 717-726.
148. Jana, M.; Dasgupta, S.; Saha, R. N.; Liu, X.; Pahan, K. Induction of tumor necrosis factor-? (TNF-?) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J. Neurochem., 2003, 86, 519-528.
149. Wilms, H.; Rosenstiel, P.; Sievers, J.; Deuschl, G.; Zecca, L.; Lucius, R. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson-s disease. FASEB J., 2003, 17, 500-502.
150. Bading, H.; Greenberg, M. E. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science, 1991, 253, 912-914.
151. Fiore, R. S.; Murphy, T. H.; Sanghera, J. S.; Pelech, S. L.; Baraban, J. M. Activation of p42 mitogen-activated protein kinase by glutamate receptor stimulation in rat primary cortical cultures. J. Neurochem., 1993, 61, 1626-1633.
152. Rosen, L. B.; Ginty, D. D.; Weber, M. J.; Greenberg, M. E. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron, 1994, 12, 1207-1221.
153. Morozov, A.; Muzzio, I. A.; Bourtchouladze, R.; Van-Strien, N.; Lapidus, K.; Yin, D.; Winder, D. G.; Adams, J. P.; Sweatt, J. D.; Kandel, E. R. Rap1 couples cAMP signaling to a distinct pool of p42/44MAPK regulating excitability, synaptic plasticity, learning, and memory. Neuron, 2003, 39, 309-325.
154. Fitzgerald, E. M. Regulation of voltage-dependent calcium channels in rat sensory neurones involves a Ras-mitogen-activated protein kinase pathway. J. Physiol., 2000, 527. 3, 433-444.
155. Han, M.; Huang, R. Y.; Du, Y. M.; Zhao, Z. Q.; Zhang, Y. Q. Early intervention of ERK activation in the spinal cord can block initiation of peripheral nerve injury-induced neuropathic pain in rats. Sheng Li Xue Bao, 2011, 63, 106-114.
156. Dai, Z.; Lin, T.; Liou, J.; Cheng, K.; Chen, J.; Chu, L.; Chen, I.; Wu, B. Xanthine derivative KMUP-1 reduces inflammation and hyperalgesia in a bilateral chronic constriction injury model by suppressing MAPK and NF?B activation. Mol. Pharm., 2014, 11, 1621-1631.
157. Ciruela, A.; Dixon, A. K.; Bramwell, S.; Gonzalez, M. I.; Pinnock, R. D.; Lee, K. Identification of MEK1 as a novel target for the treatment of neuropathic pain. Br. J. Pharmacol., 2003, 138, 751-756.
158. Tang, J.; Zhu, C.; Li, Z.; Liu, X.; Sun, S.; Zhang, T.; Luo, Z.; Zhang, H.; Li, W. Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain. J. Neuroinflammation, 2015, 12, 57.
159. Lu, Y.; Jiang, B. C.; Cao, D. L.; Zhang, Z. J.; Zhang, X.; Ji, R. R.; Gao, Y. J. TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-alpha and IL-1beta signaling. Pain, 2014, 155, 2618-2629.
160. Huang, C. T.; Tsai, Y. J. Docosahexaenoic acid confers analgesic effects after median nerve injury via inhibition of c-Jun N-terminal kinase activation in microglia. J. Nutr. Biochem., 2016, 29, 97-106.
161. Kaltschmidt, B.; Kaltschmidt, C. NF-kappaB in the nervous system. Cold Spring Harb. Perspect. Biol., 2009, 1(3), a001271.
162. Shih, R. H.; Wang, C. Y.; Yang, C. M. NF-kappaB signaling pathways in neurological inflammation: A mini review. Front. Mol. Neurosci., 2015, 8, 1-8.
163. Meunier, A.; Latremoliere, A.; Dominguez, E.; Mauborgne, A.; Philippe, S.; Hamon, M.; Mallet, J.; Benoliel, J.; Pohl, M. Lentiviral-mediated targeted NF-?B blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol. Ther., 2007, 15, 687-697.
164. Tchivileva, I. E.; Nackley, A. G.; Qian, L.; Wentworth, S.; Conrad, M.; Diatchenko, L. B. Characterization of NF-kBmediated inhibition of catechol-O-methyltransferase. Mol. Pain, 2009, 5, 13.
165. Ma, W.; Bisby, M. A. Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res., 1998, 797, 243-254.
166. Bakalkin, G.; Yakovleva, T.; Terenius, L. NF-kappa B-like factors in the murine brain. Developmentally-regulated and tissue-specific expression. Brain Res. Mol. Brain Res., 1993, 20, 137-146.
167. Kaltschmidt, C.; Kaltschmidt, B.; Baeuerle, P. A. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech. Dev., 1993, 43, 135-147.
168. Baeuerle, P. A.; Henkel, T. Function and activation of NFkappa B in the immune system. Annu. Rev. Immunol., 1994, 12, 141-179.
169. Lee, K. M.; Kang, B. S.; Lee, H. L.; Son, S. J.; Hwang, S. H.; Kim, D. S.; Park, J. S.; Cho, H. J. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur. J. Neurosci., 2004, 19, 3375-3381.
170. Pan, Y.; Guo, Q.; Wang, E.; Ye, Z.; He, Z.; Zou, W.; Cheng, Z.; Wang, Y. Intrathecal infusion of pyrrolidine dithiocarbamate for the prevention and reversal of neuropathic pain in rats using a sciatic chronic constriction injury model. Reg. Anesth. Pain Med., 2010, 35, 231-237.
171. Lee, M. K.; Han, S. R.; Park, M. K.; Kim, M. J.; Bae, Y. C.; Kim, S. K.; Park, J. S.; Ahn, D. K. Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-?B in rats with trigeminal neuropathic pain. Mol. Pain, 2011, 7, 57.
172. Zhou, C.; Shi, X.; Huang, H.; Zhu, Y.; Wu, Y. Montelukast attenuates neuropathic pain through inhibiting p38 mitogenactivated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury. Anesth. Analg., 2014, 118, 1090-1096.
173. Zhou, H.; Chen, S.; Wang, W.; Wang, Z.; Wu, X.; Zhang, Z. Nanog inhibits lipopolysaccharide-induced expression of pro-inflammatory cytokines by blocking NF-kappaB transcriptional activity in rat primary microglial cells. Mol. Med. Rep., 2012, 5, 842-846.
174. Olajide, O. A.; Aderogba, M. A.; Okorji, U. P.; Fiebich, B. L. Bridelia ferruginea produces antineuroinflammatory activity through inhibition of nuclear factor-kappa B and p38 MAPK signalling. Evid. Based. Complement. Alternat. Med., 2012, 2012, 546873.
175. Jana, M.; Jana, A.; Liu, X.; Ghosh, S.; Pahan, K. Involvement of phosphatidylinositol 3-kinase-mediated upregulation of IkappaB in anti-inflammatory effect of gemfibrozil in microglia. J. Immunol., 2007, 179, 4142-4152.
176. Dominguez, E.; Mauborgne, A.; Mallet, J.; Desclaux, M.; Pohl, M. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J. Neurosci., 2010, 30, 5754-5766.
177. Wang, N.; Liang, H.; Zen, K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol., 2014, 5, 1-9.
178. Molet, J.; Mauborgne, A.; Diallo, M.; Armand, V.; Geny, D.; Villanueva, L.; Boucher, Y.; Pohl, M. Microglial Janus kinase/signal transduction and activator of transcription 3 pathway activity directly impacts astrocyte and spinal neuron characteristics. J. Neurochem., 2015, 133-147.
179. Cianciulli, A.; Dragone, T.; Calvello, R.; Porro, C.; Trotta, T.; Lofrumento, D. D.; Panaro, M. A. IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int. Immunopharmacol., 2015, 24, 369-376.
180. Yamauchi, K.; Osuka, K.; Takayasu, M.; Usuda, N.; Nakazawa, A.; Nakahara, N.; Yoshida, M.; Aoshima, C.; Hara, M.; Yoshida, J. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J. Neurochem., 2006, 96, 1060-1070.
181. Zeng, K. W.; Wang, S.; Dong, X.; Jiang, Y.; Tu, P. F. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-?B, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways. Phytomedicine, 2014, 21, 298-306.
182. Murray, P. J. STAT3-mediated anti-inflammatory signalling. Biochem. Soc. Trans., 2006, 34, 1028-1031.
183. Scheller, J.; Chalaris, A.; Schmidt-Arras, D.; Rose-John, S. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta-Mol. Cell Res., 2011, 1813, 878-888.
184. Hay, N.; Sonenberg, N. Upstream and downstream of mTOR. Genes Dev., 2004, 18, 1926-1945.
185. Obara, I.; Tochiki, K. K.; Geranton, S. M.; Carr, F. B.; Lumb, B. M.; Liu, Q.; Hunt, S. P. Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice. Pain, 2011, 152, 2582-2595.
186. Hemmings, B. A.; Restuccia, D. F. PI3K-PKB / Akt Pathway. Cold Spring Harb. Perspect. Biol., 2012, 4, 1-4.
187. Kelly, A.; Lynch, M. Long-term potentiation in dentate gyrus of the rat is inhibited by the phosphoinositide 3-kinase inhibitor, wortmannin. Neuropharmacology, 2000, 39, 643-651.
188. Lin, X.; Bohle, A. S.; Dohrmann, P.; Leuschner, I.; Schulz, A.; Kremer, B.; Fandrich, F. Overexpression of phosphatidylinositol 3-kinase in human lung cancer. Langenbecks Arch Surg, 2001, 386, 293-301.
189. Man, H. Y.; Wang, Q.; Lu, W. Y.; Ju, W.; Ahmadian, G.; Liu, L.; D-Souza, S.; Wong, T. P.; Taghibiglou, C.; Lu, J.; Becker, L. E.; Pei, L.; Liu, F.; Wymann, M. P.; MacDonald, J. F.; Wang, Y. T. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron, 2003, 38, 611-624.
190. Sun, R.; Yan, J.; Willis, W. D. Activation of protein kinase B/Akt in the periphery contributes to pain behavior induced by capsaicin in rats. Neuroscience, 2007, 144, 286-294.
191. Xu, J. T.; Tu, H. Y.; Xin, W. J.; Liu, X. G.; Zhang, G. H.; Zhai, C. H. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp. Neurol., 2007, 206, 269-279.
192. Carvalho, T. T.; Flauzino, T.; Otaguiri, E. S.; Batistela, A. P.; Zarpelon, A. C.; Cunha, T. M.; Ferreira, S. H.; Cunha, F. Q.; Verri, W. A. Granulocyte-Colony Stimulating Factor (GCSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice. Pharmacol. Biochem. Behav., 2011, 98, 188-195.
193. Pezet, S.; Marchand, F.; D-Mello, R.; Grist, J.; Clark, A. K.; Malcangio, M.; Dickenson, A. H.; Williams, R. J.; McMahon, S. B. Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J. Neurosci., 2008, 28, 4261-4270.
194. Yu, L. N.; Zhou, X. L.; Yu, J.; Huang, H.; Jiang, L. S.; Zhang, F. J.; Cao, J. L.; Yan, M. PI3K contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs. PLoS One, 2012, 7, e40930.
195. Jin, D.; Yang, J. P.; Hu, J. H.; Wang, L. N.; Zuo, J. L. MCP-1 stimulates spinal microglia via PI3K/Akt pathway in bone cancer pain. Brain Res., 2015, 1599, 158-167.
196. Horvath, R. J.; DeLeo, J. A. Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J. Neurosci., 2009, 29, 998-1005.
197. Saponaro, C.; Cianciulli, A.; Calvello, R.; Dragone, T.; Iacobazzi, F.; Panaro, M. A. The PI3K/Akt pathway is required for LPS activation of microglial cells. Immunopharmacol. Immunotoxicol., 2012, 34, 858-865.
198. Park, H. Y.; Kim, N. D.; Kim, G. Y.; Hwang, H. J.; Kim, B. W.; Kim, W. J.; Choi, Y. H. Inhibitory effects of diallyl disulfide on the production of inflammatory mediators and cytokines in lipopolysaccharide-activated BV2 microglia. Toxicol. Appl. Pharmacol., 2012, 262, 177-184.
199. Tarassishin, L.; Suh, H. S.; Lee, S. C. Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway. J. Neuroinflammation, 2011, 8, 187.
200. Jiang, Z.; Wu, S.; Wu, X.; Zhong, J.; Lv, A.; Jiao, J.; Chen, Z. Blocking mammalian target of rapamycin alleviates bone cancer pain and morphine tolerance via ?-opioid receptor. Int. J. Cancer., 2016, 138(8), 2013-2020.
201. Jiang, S.; Zhang, Z.; Kang, L.; Wang, Q.; Zhang, L.; Chen, H. Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion. Exp Neurol., 2016, 275(Pt 1), 11-16.
202. Xu, B.; Guan, X. H.; Yu, J. X.; Lv, J.; Zhang, H. X.; Fu, Q. C.; Xiang, H. B.; Bu, H. L.; Shi, D.; Shu, B.; Qin, L. S.; Manyande, A.; Tian, Y. K. Activation of spinal phosphatidylinositol 3-kinase/protein kinase B mediates pain behavior induced by plantar incision in mice. Exp. Neurol., 2014, 255, 71-82.
203. Anand, P.; Shenoy, R.; Palmer, J. E.; Baines, A. J.; Lai, R. Y. K.; Robertson, J.; Bird, N.; Ostenfeld, T.; Chizh, B. A. Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. Eur. J. Pain, 2011, 15, 1040-1048.
204. Singh, D.; Smyth, L.; Borrill, Z.; Sweeney, L.; Tal-Singer, R. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients. J. Clin. Pharmacol., 2010, 50, 94-100.
205. Tong, S. E.; Daniels, S. E.; Black, P.; Chang, S.; Protter, a.; Desjardins, P. J. Novel p38 Mitogen-Activated Protein Kinase Inhibitor Shows Analgesic Efficacy in Acute Postsurgical Dental Pain. J. Clin. Pharmacol., 2012, 52, 717-728.
206. Pareek, A.; Suthar, M.; Rathore, G.; Bansal, V. Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn. Rev., 2011, 5, 103.
207. Studzi?ska-Sroka, E.; Znajdek-Awize?, P.; Gawron-Gzella, A. Studies on the antimigraine action of Feverfew (Tanacetum parthenium (L.) Sch. Bip.). Wiad Lek, 2013, 6, 195-199.
208. Wider B, Pittler MH, E. E. Feverfew for preventing migraine. Cochrane Database Syst Rev., 2015, CD002286.
209. Sen, M.; Thomas, S. M.; Kim, S.; Yeh, J. I.; Ferris, R. L.; Johnson, J. T.; Duvvuri, U.; Lee, J.; Sahu, N.; Joyce, S.; Freilino, M. L.; Shi, H.; Li, C.; Ly, D.; Rapireddy, S.; Jonathan, P.; Li, P.; Wang, L.; Chiosea, S.; Seethala, R. R.; Gooding, W. E. First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov., 2012, 2, 694-705.
210. Bendell, J. C.; Hong, D. S.; Burris, H. A.; Naing, A.; Jones, S. F.; Falchook, G.; Bricmont, P.; Elekes, A.; Rock, E. P.; Kurzrock, R. Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors. Cancer Chemother. Pharmacol., 2014, 74, 125-130.